Diamond Therapeutics is revolutionizing the treatment of mental health by developing FDA-approved, psilocybin-based therapeutics that deliver patient benefits without undesired perceptual side effects, such as hallucinations. They're taking a rigorous scientific approach with a strong patent position, looking to clinically validate their molecules and find the right dosage that still maximizes clinical effects but allows for patients to have normal function (testing single ascending dose, multiple ascending dose and multiple in patient doses).